Shares of USSG Now Oversold
- USSG RSI Reading: USSG's Relative Strength Index (RSI) reading is at 29.7, indicating a potential exhaustion of recent heavy selling.
- Comparison with S&P 500: The S&P 500's RSI reading is currently 32.0, slightly higher than USSG's RSI.
- Stock Performance: USSG's 52-week range shows a low point of $36.87 per share and a high point of $49.505 per share, with the last trade at $46.14.
- Current Trading: USSG shares are down approximately 1.2% for the day.
- Author's Disclaimer: The views expressed in the content are those of the author and may not represent Nasdaq, Inc.'s opinions.
Trade with 70% Backtested Accuracy
Analyst Views on USSG
About the author
USSG Set to Reach $68: Understanding the Factors Involved
ETF Analysis: The Xtrackers MSCI USA ESG Leaders Equity ETF (USSG) has an implied analyst target price of $68.38, indicating a potential upside of 10.59% from its current trading price of $61.83.
Notable Holdings: Key underlying holdings with significant upside potential include Cintas Corporation (CTAS), Nucor Corp. (NUE), and PulteGroup Inc (PHM), with expected price increases of 15.22%, 14.53%, and 13.28% respectively based on analyst targets.
Explore the Potential: USSG Could Rise by 11%
ETF Analysis: The Xtrackers MSCI USA ESG Leaders Equity ETF (USSG) has an implied analyst target price of $67.32, indicating a potential upside of 10.93% from its current trading price of $60.69.
Notable Holdings: Key underlying holdings with significant upside potential include International Flavors & Fragrances Inc. (33.22% upside), Royalty Pharma plc (23.25% upside), and Target Corp (20.77% upside) based on their respective analyst target prices.
Investor Considerations: Questions arise regarding the validity of these analyst targets, as high price targets may reflect optimism but could also lead to downgrades if they are based on outdated information.
Further Research Needed: Investors are encouraged to conduct additional research to assess whether analysts' targets are justified or overly optimistic in light of recent developments in the companies and their industries.
Shares of USSG Now Oversold
USSG Set to Reach $68: Understanding the Factors Involved
ETF Analysis: The Xtrackers MSCI USA ESG Leaders Equity ETF (USSG) has an implied analyst target price of $68.38, indicating a potential upside of 10.59% from its current trading price of $61.83.
Notable Holdings: Key underlying holdings with significant upside potential include Cintas Corporation (CTAS), Nucor Corp. (NUE), and PulteGroup Inc (PHM), with expected price increases of 15.22%, 14.53%, and 13.28% respectively based on analyst targets.
Explore the Potential: USSG Could Rise by 11%
ETF Analysis: The Xtrackers MSCI USA ESG Leaders Equity ETF (USSG) has an implied analyst target price of $67.32, indicating a potential upside of 10.93% from its current trading price of $60.69.
Notable Holdings: Key underlying holdings with significant upside potential include International Flavors & Fragrances Inc. (33.22% upside), Royalty Pharma plc (23.25% upside), and Target Corp (20.77% upside) based on their respective analyst target prices.
Investor Considerations: Questions arise regarding the validity of these analyst targets, as high price targets may reflect optimism but could also lead to downgrades if they are based on outdated information.
Further Research Needed: Investors are encouraged to conduct additional research to assess whether analysts' targets are justified or overly optimistic in light of recent developments in the companies and their industries.
Shares of USSG Now Oversold
